GEODE CAPITAL MANAGEMENT, LLC - CONTRAVIR PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRV and the CUSIP is 21234W202. A total of 20 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$14,000
-58.8%
62,817
-50.0%
0.00%–
Q4 2018$34,000
-2.9%
125,634
+100.0%
0.00%–
Q3 2018$35,000
-56.8%
62,8170.0%0.00%–
Q2 2018$81,000–62,817–0.00%–
 Download
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
HighTower Advisors, LLC 129,733$73,0000.00%
BARCLAYS PLC 54,522$31,0000.00%
ROYAL BANK OF CANADA 7$00.00%
VANGUARD GROUP INC 325,575$183,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 3,280$2,0000.00%
Capital Advisors, Ltd. LLC 22$00.00%
UBS Group AG 9,350$5,0000.00%
Advisor Group, Inc. 35$00.00%
WELLS FARGO & COMPANY/MN 316$00.00%
NORTHERN TRUST CORP 19,935$11,0000.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders